Posted by Michael Wonder on 24 Oct 2023
Insulin is increasingly affordable in the US. What about the rest of the world?
24 October 2023 - In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers — committed to reducing the US list price of insulin, a drug that millions of people require to live.
Following two decades of sharp increases for consumers, the companies vowed to cut insulin prices for some insulins by at least 70%, meaning many people could see their insulin costs capped at $35 a month in the near future. (Sanofi and NovoNordisk will lower their prices as of January 2024; Lilly reduced it to $35 per month in March 2023.)
